Mark Iwanochko

669 total citations
13 papers, 397 citations indexed

About

Mark Iwanochko is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Mark Iwanochko has authored 13 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Organic Chemistry. Recurrent topics in Mark Iwanochko's work include Lysosomal Storage Disorders Research (5 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Glycogen Storage Diseases and Myoclonus (1 paper). Mark Iwanochko is often cited by papers focused on Lysosomal Storage Disorders Research (5 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Glycogen Storage Diseases and Myoclonus (1 paper). Mark Iwanochko collaborates with scholars based in Canada, Netherlands and United Kingdom. Mark Iwanochko's co-authors include Robert J. Cusimano, Jagdish Butany, Warren J. Cantor, Donald A.G. Mickle, Zhiqiang Jia, Ren‐Ke Li, Terrence M. Yau, Shinji Tomita, Mansoor Husain and Tetsuro Sakai and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Mark Iwanochko

12 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Iwanochko Canada 7 139 128 91 83 81 13 397
Valeri Kolpakov Russia 8 132 0.9× 109 0.9× 24 0.3× 96 1.2× 17 0.2× 11 452
Qasim Ahmad United States 7 207 1.5× 79 0.6× 55 0.6× 203 2.4× 22 0.3× 16 458
Bianca Visciano Italy 10 233 1.7× 26 0.2× 115 1.3× 63 0.8× 65 0.8× 19 439
Van Thi Nguyen Italy 11 53 0.4× 81 0.6× 43 0.5× 65 0.8× 48 0.6× 14 299
Liping Ma China 11 33 0.2× 93 0.7× 44 0.5× 128 1.5× 55 0.7× 20 385
Michael Reynolds United States 10 73 0.5× 73 0.6× 38 0.4× 230 2.8× 55 0.7× 15 420
Lei Qian China 13 54 0.4× 101 0.8× 57 0.6× 141 1.7× 9 0.1× 46 482
Mark Piegore United States 5 110 0.8× 75 0.6× 57 0.6× 125 1.5× 96 1.2× 7 389
Mitsuhiro Abe Japan 12 128 0.9× 39 0.3× 52 0.6× 106 1.3× 27 0.3× 55 531
Ranhua Jiang China 8 36 0.3× 126 1.0× 66 0.7× 89 1.1× 133 1.6× 15 326

Countries citing papers authored by Mark Iwanochko

Since Specialization
Citations

This map shows the geographic impact of Mark Iwanochko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Iwanochko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Iwanochko more than expected).

Fields of papers citing papers by Mark Iwanochko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Iwanochko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Iwanochko. The network helps show where Mark Iwanochko may publish in the future.

Co-authorship network of co-authors of Mark Iwanochko

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Iwanochko. A scholar is included among the top collaborators of Mark Iwanochko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Iwanochko. Mark Iwanochko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
West, Michael L., et al.. (2023). Early therapy in Fabry disease: Outcomes from the Canadian Fabry Disease Initiative (CFDI) registry. Molecular Genetics and Metabolism. 138(2). 107357–107357.
2.
Arends, Maarten, Marieke Biegstraaten, Christoph Wanner, et al.. (2018). Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study. Journal of Medical Genetics. 55(5). 351–358. 81 indexed citations
3.
Hollak, Carla E. M., Maarten Arends, Christoph Wanner, et al.. (2018). Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: An international cohort study. Molecular Genetics and Metabolism. 123(2). S64–S65. 1 indexed citations
4.
Mohan, Ravi, et al.. (2015). Unusual Intense Fluorodeoxyglucose Uptake in the Intercostal Muscles Due to Severe Shortness of Breath in a Patient with Heart Failure. SHILAP Revista de lepidopterología. 14(1). 66–67. 3 indexed citations
5.
Hall, Allison B., Jennifer M. Renaud, J. Matthew Brennan, et al.. (2011). 516 Cardiac fdg pet results impact decisions and identify patients likely to benefit from revascularization in a multi-center provincial registry (CADRE). Canadian Journal of Cardiology. 27(5). S249–S250. 2 indexed citations
6.
Ziadi, María Cecilia, Robert A. deKemp, Jennifer M. Renaud, et al.. (2009). Abstract 517: FDG PET Imaging Positively Impacts Management Direction and Predicts Outcomes in a Multicenter 'Real World' Setting. Circulation. 120. 2 indexed citations
7.
Karski, Jacek, George Djaiani, Jo Carroll, et al.. (2005). Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: A prospective randomized controlled clinical trial. Journal of Thoracic and Cardiovascular Surgery. 130(2). 309–314. 32 indexed citations
8.
Johnson, Sindhu R., Paula Harvey, John S. Floras, et al.. (2004). Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations. Lupus. 13(8). 590–593. 40 indexed citations
9.
Li, Ren‐Ke, Richard D. Weisel, Donald A.G. Mickle, et al.. (2000). Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. Journal of Thoracic and Cardiovascular Surgery. 119(1). 62–68. 134 indexed citations
10.
Cantor, Warren J., Jagdish Butany, Mark Iwanochko, & Peter Liu. (1998). Restrictive Cardiomyopathy Secondary to Fabry’s Disease. Circulation. 98(14). 1457–1459. 23 indexed citations
11.
Cantor, Warren J., Paul Daly, Mark Iwanochko, et al.. (1998). Cardiac transplantation for Fabry's disease.. PubMed. 14(1). 81–4. 35 indexed citations
12.
Liu, Peter, Mark Henkelman, J Joshi, et al.. (1996). Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model.. PubMed. 12(2). 155–64. 40 indexed citations
13.
Horgen, Paul A., et al.. (1983). Antheridiol, RNA polymerase II and sexual development in the aquatic fungus, Achlya. Archives of Microbiology. 134(4). 314–319. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeri Kolpakov Breakdown of academic impact, for papers by Qasim Ahmad Breakdown of academic impact, for papers by Bianca Visciano Breakdown of academic impact, for papers by Van Thi Nguyen Breakdown of academic impact, for papers by Liping Ma Breakdown of academic impact, for papers by Michael Reynolds Breakdown of academic impact, for papers by Lei Qian Breakdown of academic impact, for papers by Mark Piegore Breakdown of academic impact, for papers by Mitsuhiro Abe Breakdown of academic impact, for papers by Ranhua Jiang
Rankless by CCL
2026